Technology exploitation paths combining technological and complementary resources in new product development and licensing: Revision history

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

    9 August 2022

    • curprev 04:1704:17, 9 August 2022‎ 179.215.124.0 talk‎ 670 bytes +670‎ Created page with "== Target Article == Technology exploitation paths combining technological and complementary resources in new product development and licensing; M Bianchi, F Frattini, J Lejarragaae; 2014; doi_citing_unknown == Retraction == Retraction: Long-term survival results of a randomized trial comparing gemcitabine/cisplatin and methotrexate/vinblastine/doxorubicin/ cisplatin in patients with locally advanced and metastatic bladder cancer (DOI:10.1093/annonc/mdj965); J. T. Robert..."
Retrieved from "https://wikicitingretracted.org/index.php?title=Technology_exploitation_paths_combining_technological_and_complementary_resources_in_new_product_development_and_licensing"